Bionews Evolves Brand Identity with Bold New Look, Same Powerful Voice for Rare Disease Communities
Bionews, the nation’s largest and most trusted network of rare disease communities, today unveiled a new brand identity reflecting its ongoing commitment to supporting patients and fostering meaningful connections. Our brand refresh goes beyond aesthetics; it embodies...Mayo Clinic PaSAGE Study Team and BioNews Collaborates to Advance Rare Disease Awareness
The Mayo Clinic PaSAGE Study Team has announced a collaboration with BioNews to inform the future of rare disease care. This collaboration aims to understand the potential impacts of genetic therapies on patient communities and advocate for the creation and...Unlocking Clinical Trial Recruitment Success: Bionews Presents at World Orphan Drug Congress 2024
The session will highlight how Bionews’ large reach and access among rare disease patients, combined with strong community activation expertise and a patient-centric approach, accelerates trial recruitment programs. During the presentation, Bionews also will share key...
Bionews announces poster win in trial methodology category at 2023 CNS Summit
Winning poster presentation highlights company’s accelerated ability to connect patient communities with clinical trials.
Bionews empowers Friedreich’s Ataxia community with inaugural live webinar
Panel of experts and patients provided tips on management, treatment, and financial planning for Friedreich’s Ataxia patients and caregivers.